VitalNext Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Investors
  • 7

VitalNext General Information

Description

Provider of innovative life science products intended to offer health benefits to the aging population. The company's products build a bridge between the products and the market for consumer products that aid in living longer in a healthy way and provide preclinical and clinical development programs to generate value for the products, enabling people to stay aware of and enjoy healthy aging and to stay in good health for prolonged periods of time.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Personal Products
Drug Discovery
Primary Office
  • J.H. Oortweg 19
  • 2333 CH Leiden
  • Netherlands
+31 071 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VitalNext Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 07-Oct-2020 00.000 Completed Generating Revenue
3. Early Stage VC 25-Feb-2016 00.000 Completed Generating Revenue
2. Grant 05-Nov-2013 $273K $1.98M Completed Startup
1. Early Stage VC 04-Jul-2013 $1.98M $1.98M Completed Startup
To view VitalNext’s complete valuation and funding history, request access »

VitalNext Patents

VitalNext Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2016282923-B2 Compositions and methods for the treatment of malnutrition Active 26-Jun-2015 00000000000
EP-3313207-B1 Compositions and methods for the treatment of malnutrition Active 26-Jun-2015 00000000000 0
EP-3313207-A1 Compositions and methods for the treatment of malnutrition Active 26-Jun-2015 00000000000
ES-2775610-T3 Compositions and methods for treating malnutrition Active 26-Jun-2015 00000000000
JP-6851086-B2 Compositions and methods for treating malnutrition Active 26-Jun-2015 A61K38/1709
To view VitalNext’s complete patent history, request access »

VitalNext Executive Team (4)

Name Title Board Seat Contact Info
Rein Strijker Ph.D Chief Executive Officer & Founder
Mischa Strijder Chief Business Officer
Gerben Zondag Ph.D Vice President Technology Affairs
Rudy Mareel Executive Chairman
To view VitalNext’s complete executive team members history, request access »

VitalNext Board Members (4)

Name Representing Role Since
Dharminder Chahal Self Supervisory Board Member 000 0000
Rudy Mareel Self Executive Chairman 000 0000
Willem De Vos Ph.D Self Supervisory Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

VitalNext Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
LRM Venture Capital Minority 000 0000 000000 0
Oost NL Venture Capital Minority 000 0000 000000 0
Samenwerkingsverband Noord-Nederland Government Minority 000 0000 000000 0
Galapagos (Biotechnology) Corporation Minority 000 0000 000000 0
Hanzepoort Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »